257 related articles for article (PubMed ID: 25060826)
1. Mesenchymal stem cells expressing therapeutic genes induce autochthonous prostate tumour regression.
Abrate A; Buono R; Canu T; Esposito A; Del Maschio A; Lucianò R; Bettiga A; Colciago G; Guazzoni G; Benigni F; Hedlund P; Altaner C; Montorsi F; Cavarretta IT
Eur J Cancer; 2014 Sep; 50(14):2478-88. PubMed ID: 25060826
[TBL] [Abstract][Full Text] [Related]
2. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice.
Kucerova L; Matuskova M; Pastorakova A; Tyciakova S; Jakubikova J; Bohovic R; Altanerova V; Altaner C
J Gene Med; 2008 Oct; 10(10):1071-82. PubMed ID: 18671316
[TBL] [Abstract][Full Text] [Related]
3. Long-term efficiency of mesenchymal stromal cell-mediated CD-MSC/5FC therapy in human melanoma xenograft model.
Kucerova L; Skolekova S; Demkova L; Bohovic R; Matuskova M
Gene Ther; 2014 Oct; 21(10):874-87. PubMed ID: 25056607
[TBL] [Abstract][Full Text] [Related]
4. Intrinsic properties of tumour cells have a key impact on the bystander effect mediated by genetically engineered mesenchymal stromal cells.
Matuskova M; Baranovicova L; Kozovska Z; Durinikova E; Pastorakova A; Hunakova L; Waczulikova I; Nencka R; Kucerova L
J Gene Med; 2012 Dec; 14(12):776-87. PubMed ID: 23150190
[TBL] [Abstract][Full Text] [Related]
5. Human adipose tissue-derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma.
Altanerova V; Cihova M; Babic M; Rychly B; Ondicova K; Mravec B; Altaner C
Int J Cancer; 2012 May; 130(10):2455-63. PubMed ID: 21732344
[TBL] [Abstract][Full Text] [Related]
6. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
[TBL] [Abstract][Full Text] [Related]
7. Combined treatment, based on lysomustine administration with mesenchymal stem cells expressing cytosine deaminase therapy, leads to pronounced murine Lewis lung carcinoma growth inhibition.
Krassikova LS; Karshieva SS; Cheglakov IB; Belyavsky AV
J Gene Med; 2016 Sep; 18(9):220-33. PubMed ID: 27461566
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells.
Yi BR; Hwang KA; Kang NH; Kim SU; Jeung EB; Kim HC; Choi KC
Cancer Gene Ther; 2012 Sep; 19(9):644-51. PubMed ID: 22790964
[TBL] [Abstract][Full Text] [Related]
9. Cytosine deaminase-expressing human neural stem cells inhibit tumor growth in prostate cancer-bearing mice.
Lee HJ; Doo SW; Kim DH; Cha YJ; Kim JH; Song YS; Kim SU
Cancer Lett; 2013 Jul; 335(1):58-65. PubMed ID: 23391716
[TBL] [Abstract][Full Text] [Related]
10. Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy.
Kucerova L; Altanerova V; Matuskova M; Tyciakova S; Altaner C
Cancer Res; 2007 Jul; 67(13):6304-13. PubMed ID: 17616689
[TBL] [Abstract][Full Text] [Related]
11. Adipose tissue-derived mesenchymal stem cells expressing prodrug-converting enzyme inhibit human prostate tumor growth.
Cavarretta IT; Altanerova V; Matuskova M; Kucerova L; Culig Z; Altaner C
Mol Ther; 2010 Jan; 18(1):223-31. PubMed ID: 19844197
[TBL] [Abstract][Full Text] [Related]
12. Complete regression of glioblastoma by mesenchymal stem cells mediated prodrug gene therapy simulating clinical therapeutic scenario.
Altaner C; Altanerova V; Cihova M; Ondicova K; Rychly B; Baciak L; Mravec B
Int J Cancer; 2014 Mar; 134(6):1458-65. PubMed ID: 24038033
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of suicide gene-transferred mesenchymal stem cells in a rat model of glioma.
Kosaka H; Ichikawa T; Kurozumi K; Kambara H; Inoue S; Maruo T; Nakamura K; Hamada H; Date I
Cancer Gene Ther; 2012 Aug; 19(8):572-8. PubMed ID: 22744211
[TBL] [Abstract][Full Text] [Related]
14. Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases.
Matuskova M; Kozovska Z; Toro L; Durinikova E; Tyciakova S; Cierna Z; Bohovic R; Kucerova L
J Exp Clin Cancer Res; 2015 Apr; 34(1):33. PubMed ID: 25884597
[TBL] [Abstract][Full Text] [Related]
15. Suicide gene therapy with the yeast fusion gene cytosine deaminase/uracil phosphoribosyltransferase is not enough for pancreatic cancer.
Fogar P; Navaglia F; Basso D; Greco E; Zambon CF; Fadi E; Falda A; Stranges A; Vannozzi F; Danesi R; Pedrazzoli S; Plebani M
Pancreas; 2007 Oct; 35(3):224-31. PubMed ID: 17895842
[TBL] [Abstract][Full Text] [Related]
16. Genetically engineered mesenchymal stromal cells producing TNFα have tumour suppressing effect on human melanoma xenograft.
Tyciakova S; Matuskova M; Bohovic R; Polakova K; Toro L; Skolekova S; Kucerova L
J Gene Med; 2015; 17(1-2):54-67. PubMed ID: 25677845
[TBL] [Abstract][Full Text] [Related]
17. Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models.
Kang NH; Hwang KA; Yi BR; Lee HJ; Jeung EB; Kim SU; Choi KC
Cancer Gene Ther; 2012 Jun; 19(6):412-9. PubMed ID: 22498724
[TBL] [Abstract][Full Text] [Related]
18. Targeted inhibition of osteosarcoma tumor growth by bone marrow-derived mesenchymal stem cells expressing cytosine deaminase/5-fluorocytosine in tumor-bearing mice.
NguyenThai QA; Sharma N; Luong do H; Sodhi SS; Kim JH; Kim N; Oh SJ; Jeong DK
J Gene Med; 2015; 17(3-5):87-99. PubMed ID: 25808408
[TBL] [Abstract][Full Text] [Related]
19. Isocytosine deaminase Vcz as a novel tool for the prodrug cancer therapy.
Kazlauskas A; Darinskas A; Meškys R; Tamašauskas A; Urbonavičius J
BMC Cancer; 2019 Mar; 19(1):197. PubMed ID: 30832616
[TBL] [Abstract][Full Text] [Related]
20. [Mesenchymal stem cells expressing cytosine deaminase inhibit growth of murine melanoma B16F10 in vivo].
Krasikova LS; Karshieva SS; Cheglakov IB; Belyavsky AV
Mol Biol (Mosk); 2015; 49(6):1007-15. PubMed ID: 26710783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
